ncRNAs-mediated overexpression of TET3 predicts unfavorable prognosis and correlates with immunotherapy efficacy in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ncRNAs-mediated overexpression of TET3 predicts unfavorable prognosis and correlates with immunotherapy efficacy in breast cancer

Published:2024-02 Issue:3 Volume:10 Page:e24855
ISSN:2405-8440
Container-title:Heliyon
language:en
Short-container-title:Heliyon

Author:

Liu Yiyuan^ORCID,Wu Jinyao,Chen Lingzhi,Zou Juan,Yang Qiuping,Tian Huiting,Zheng Daitian,Ji Zeqi,Cai Jiehui,Li Zhiyang,Chen Yexi

Publisher

Elsevier BV

Reference84 articles.

1. Breast cancer-Epidemiology, risk factors, classification, prognostic markers, and current treatment strategies-an updated review;Łukasiewicz;Cancers,2021

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

3. Awareness and current knowledge of breast cancer;Akram;Biol. Res.,2017

4. Differences in breast cancer survival by molecular subtypes in the United States;Howlader;Cancer Epidemiol. Biomarkers Prev.,2018

5. Long non-coding RNA HUMT hypomethylation promotes lymphangiogenesis and metastasis via activating FOXK1 transcription in triple-negative breast cancer;Zheng;J. Hematol. Oncol.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MiR-26b-5p/TET3 regulates the osteogenic differentiation of human bone mesenchymal stem cells and bone reconstruction in female rats with calvarial defects;Molecular Biology Reports;2024-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP